Targeting Autophagy in Cancer: Update on Clinical Trials and Novel Inhibitors

By Chude Cynthia I.   Amaravadi Ravi K.  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-06 ,pp. : 1279-1279

MDPI

Access to resources Recommend Favorite

Therapeutic Potential of Targeting the Ghrelin Pathway

By Colldén Gustav   Tschöp Matthias H.   Müller Timo D.  

International Journal of Molecular Sciences, Vol. 18, Iss. 4, 2017-04 ,pp. : 798-798

MDPI

Access to resources Recommend Favorite

The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments

By Machado-Vieira Rodrigo   Baumann Jacqueline   Wheeler-Castillo Cristina   Latov David   Henter Ioline D.   Salvadore Giacomo   Zarate Carlos A.  

Pharmaceuticals, Vol. 3, Iss. 1, 2010-01 ,pp. : 19-41

MDPI

Access to resources Recommend Favorite

Chemical Inhibitors and microRNAs (miRNA) Targeting the Mammalian Target of Rapamycin (mTOR) Pathway: Potential for Novel Anticancer Therapeutics

By AlQurashi Naif   Hashimi Saeed M.   Wei Ming Q.  

International Journal of Molecular Sciences, Vol. 14, Iss. 2, 2013-02 ,pp. : 3874-3900

MDPI

Access to resources Recommend Favorite

By-Passing Large Screening Experiments Using Sequencing as a Tool to Identify scFv Fragments Targeting Atherosclerotic Lesions in a Novel In Vivo Phage Display Selection

By Deramchia Kamel   Jacobin-Valat Marie-Josee   Laroche-Traineau Jeanny   Bonetto Stephane   Sanchez Stephane   Dos Santos Pierre   Massot Philippe   Franconi Jean-Michel   Martineau Pierre   Clofent-Sanchez Gisele  

International Journal of Molecular Sciences, Vol. 13, Iss. 6, 2012-06 ,pp. : 6902-6923

MDPI

Access to resources Recommend Favorite